SCHEMBL253205

SCHEMBL253205

NNC(=O)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15094128 0.96
SCHEMBL7274505 0.96
Hydrochloric Acid SCHEMBL9547493 0.96
SCHEMBL2248541 0.96 CYP1A2 (0.47)
SCHEMBL11611162 0.96 CYP1A2 (0.47)
Hydrazine SCHEMBL23925257 0.96
Ammonia Solution, Strong SCHEMBL7271338 0.96
SCHEMBL28006534 0.70
Methylamine SCHEMBL6744164 0.67
Hydrazinecarboxamide SCHEMBL15393 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 484 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250243326-A1 METHOD OF PREPARING A HYDROGEL PRODUCT Galderma Holding SA (CH) 2025-07-31 US claimed
US-12252594-B2 Method of preparing a hydrogel product Galderma Holding SA (CH) 2025-03-18 US claimed
EP-3623390-B1 CARBOHYDRATE CROSSLINKER GALDERMA SA (CH) 2023-08-02 EP claimed
US-20230174965-A1 METHODS AND PRODUCTS UNIV BIRMINGHAM (GB) 2023-06-08 US claimed
US-20230142126-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASES HEALION BIO., INC. (US) 2023-05-11 US claimed
EP-4149552-A1 COMPOSITIONS AND METHODS FOR INCREASING EFFICACY OF A DRUG Healion Bio, Inc. (US) 2023-03-22 EP claimed
EP-4136223-A2 METHODS AND PRODUCTS The University Of Birmingham (GB) 2023-02-22 EP claimed
WO-2022072504-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASES HEALION BIO, INC. (US) 2022-04-07 WO claimed
WO-2021233534-A1 USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND MEDICAL TREATMENTS OR USES THEREOF PVAC MEDICAL TECHNOLOGIES LTD (CY) 2021-11-25 WO claimed
WO-2021231872-A1 COMPOSITIONS AND METHODS FOR INCREASING EFFICACY OF A DRUG HEALION BIO, INC. (US) 2021-11-18 WO claimed
US-5730990-A Non-antigenic amine derived polymers and polymer conjugates ENZON, INC. (US) 1998-03-24 US claimed
US-5643575-A Non-antigenic branched polymer conjugates ENZON, INC. (US) 1997-07-01 US claimed
EP-0247724-B1 THIADIAZINON DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1991-09-11 EP claimed
EP-0085227-B1 THIADIAZINE DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-04-03 EP claimed
US-4558045-A CARDIOTONIC AND HYPOTENSIVE ACTIVITY IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) 1985-12-10 US claimed
EP-0052442-B1 HETEROCYCLIC COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-09-11 EP claimed
EP-0086301-A1 Thiadiazine, oxadiazine and triazine derivatives and pharmaceutical compositions containing them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1983-08-24 EP claimed
EP-0085227-A1 Thiadiazine derivatives, and pharmaceutical compositions containing them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1983-08-10 EP claimed
EP-0080296-A1 Pharmaceutically active phenyl-thia-, oxa- or triazinones IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1983-06-01 EP claimed
EP-0052442-A1 Heterocyclic compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-05-26 EP claimed